| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Isotretinoin | FAERS: 92 | US FAERS | |
| 2 | Sorafenib | FAERS: 5 | US FAERS | |
| 3 | tofacitinib | FAERS: 5 | US FAERS | |
| 4 | Capecitabine | FAERS: 4 | US FAERS | |
| 5 | Lenalidomide | FAERS: 4 | US FAERS | |
| 6 | Olmesartan Medoxomil | FAERS: 4 | US FAERS | |
| 7 | Sunitinib | FAERS: 4 | SIDER US FAERS | |
| 8 | Dimethyl Fumarate | FAERS: 3 | US FAERS | |
| 9 | Everolimus | FAERS: 3 | US FAERS | |
| 10 | Temozolomide | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Clomiphene | FAERS: 2 | US FAERS | |
| 12 | Deferasirox | FAERS: 2 | US FAERS | |
| 13 | Erlotinib Hydrochloride | FAERS: 2 | US FAERS | |
| 14 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 15 | Quetiapine Fumarate | FAERS: 2 | US FAERS | |
| 16 | apremilast | FAERS: 2 | US FAERS | |
| 17 | pazopanib | FAERS: 2 | US FAERS | |
| 18 | regorafenib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 1 | US FAERS | |
| 20 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 21 | Budesonide | FAERS: 1 | US FAERS | |
| 22 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 23 | Cytarabine | FAERS: 1 | US FAERS | |
| 24 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 25 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 26 | Iron citrate | FAERS: 1 | US FAERS | |
| 27 | Mesalamine | FAERS: 1 | US FAERS | |
| 28 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | FAERS: 1 | US FAERS | |
| 29 | Naproxen | FAERS: 1 | US FAERS | |
| 30 | Norgestrel | FAERS: 1 | US FAERS | |
| 31 | NuvaRing | FAERS: 1 | US FAERS | |
| 32 | Omeprazole | FAERS: 1 | US FAERS | |
| 33 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 34 | Rasilez HCT | FAERS: 1 | US FAERS | |
| 35 | Thalidomide | FAERS: 1 | US FAERS | |
| 36 | Thioctic Acid | FAERS: 1 | US FAERS | |
| 37 | Vemurafenib | FAERS: 1 | US FAERS | |
| 38 | Warfarin | FAERS: 1 | US FAERS | |
| 39 | cabozantinib | FAERS: 1 | US FAERS | |
| 40 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 41 | ledipasvir, sofosbuvir drug combination | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | rofecoxib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.